Viewing Study NCT06259058


Ignite Creation Date: 2025-12-25 @ 12:05 AM
Ignite Modification Date: 2026-03-01 @ 4:45 PM
Study NCT ID: NCT06259058
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-15
First Post: 2024-02-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module